BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9827191)

  • 1. [Chemical labyrinthectomy: results and applications].
    Mondain M; Mouchet F; Marlier F; Makeieff M; Biboulet R; Uziel A
    Ann Otolaryngol Chir Cervicofac; 1998 Oct; 115(4):234-42. PubMed ID: 9827191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.
    Schmerber S; Dumas G; Morel N; Chahine K; Karkas A
    Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Menière's disease.
    Nedzelski JM; Schessel DA; Bryce GE; Pfleiderer AG
    Am J Otol; 1992 Jan; 13(1):18-22. PubMed ID: 1598978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin in Ménière's disease: results of therapy.
    Murofushi T; Halmagyi GM; Yavor RA
    Am J Otol; 1997 Jan; 18(1):52-7. PubMed ID: 8989952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vestibular neurotomy versus chemical labyrinthectomy for disabling Menière disease].
    Morel N; Dumas G; Nguyen DQ; Mohr E; Hitter A; Schmerber S
    Ann Otolaryngol Chir Cervicofac; 2005 Dec; 122(6):271-80. PubMed ID: 16505777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial.
    Postema RJ; Kingma CM; Wit HP; Albers FW; Van Der Laan BF
    Acta Otolaryngol; 2008 Aug; 128(8):876-80. PubMed ID: 18607963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acetyl-DL-leucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy.
    Ferber-Viart C; Dubreuil C; Vidal PP
    Audiol Neurootol; 2009; 14(1):17-25. PubMed ID: 18663295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of labyrinthectomy in the treatment of Menière's disease and delayed endolymphatic hydrops.
    Yazdi AK; Rutka J
    J Otolaryngol; 1996 Feb; 25(1):26-31. PubMed ID: 8816106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meniere's disease: diagnosis and new treatment perspectives].
    Quaranta A; Piazza F
    Recenti Prog Med; 2000 Jan; 91(1):33-7. PubMed ID: 10705783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS; Lai JT
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.
    Casani A; Nuti D; Franceschini SS; Gaudini E; Dallan I
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):929-35. PubMed ID: 16360516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.